Literature DB >> 18565905

Complexities in interpretation of osteosarcoma clinical trial results.

Sally Hunsberger, Boris Freidlin, Malcolm A Smith.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18565905     DOI： 10.1200/JCO.2008.17.3484

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Mifamurtide: a review of its use in the treatment of osteosarcoma.

Authors:  James E Frampton
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

Review 2.  Mifamurtide for the treatment of nonmetastatic osteosarcoma.

Authors:  Kosei Ando; Kanji Mori; Nedège Corradini; Françoise Redini; Dominique Heymann
Journal:  Expert Opin Pharmacother       Date:  2011-02       Impact factor: 3.889

3.  Review of mifamurtide in the treatment of patients with osteosarcoma.

Authors:  Leo Kager; Ulrike Pötschger; Stefan Bielack
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

Review 4.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

5.  Comment on: 'Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?'.

Authors:  S S Bielack
Journal:  Br J Cancer       Date:  2012-06-28       Impact factor: 7.640

Review 6.  The new deal: a potential role for secreted vesicles in innate immunity and tumor progression.

Authors:  Alberto Benito-Martin; Angela Di Giannatale; Sophia Ceder; Héctor Peinado
Journal:  Front Immunol       Date:  2015-02-24       Impact factor: 7.561

Review 7.  Advances in the management of osteosarcoma.

Authors:  Stefan S Bielack; Stefanie Hecker-Nolting; Claudia Blattmann; Leo Kager
Journal:  F1000Res       Date:  2016-11-25

Review 8.  Translation of peptidoglycan metabolites into immunotherapeutics.

Authors:  Matthew E Griffin; Charles W Hespen; Yen-Chih Wang; Howard C Hang
Journal:  Clin Transl Immunology       Date:  2019-11-29

Review 9.  Microenvironmental Targets in Sarcoma.

Authors:  Monika Ehnman; Olle Larsson
Journal:  Front Oncol       Date:  2015-11-04       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.